TopAbstracts in Influenza 07/03/2008 TopAbstracts in Influenza are the abstracts most highly rated/most read by nearly 300,000 physicians who received a Doctor's Guide newsletter or visited a website Powered by Doctor's Guide in the past 28 days.Over 2000 peer-reviewed...
Call for mass child hepatitis B jab Children should be vaccinated against hepatitis to prevent the spread of medicine-resistant strains of the disease, according to a report published by The Association of The British Pharmaceutical Industry (ABPI).Strains of hepatitis B...
Blood Components ABS is skilled in isolating purified blood cell populations, blood platelets, blood proteins, and blood fractions from human and animal blood.For example, we routinely prepare: neutrophils eosinophils platelets plasma red blood cells...
Key Challenges and Issues facing the World Immunoassay Instruments Market IMMUNOASSAY INSTRUMENTS MCP-3522 A GLOBAL STRATEGIC BUSINESS REPORT CONTENTS I.INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS Study Reliability and Reporting Limitations I-1 Disclaimers I-2 Data Interpretation & Reporting...
Entecavir therapy for lamivudine-refractory chronic hepatitis B: Improved virologic, biochemical, and serology Hepatitis B Articles (HBV) Back  Entecavir therapy for lamivudine-refractory chronic hepatitis B: Improved virologic, biochemical, and serology outcomes through 96 weeks Hepatology July 1, 2008 Morris Sherman 1 *, Cihan...
Children Must Be Protected Against Hepatitis, Warns ABPI _ Children Must Be Protected Against Hepatitis, Warns ABPI.
TopAbstracts in Cirrhosis 07/01/2008 TopAbstracts in Cirrhosis are the abstracts most highly rated/most read by nearly 300,000 physicians who received a Doctor's Guide newsletter or visited a website Powered by Doctor's Guide in the past 28 days.Over 2000 peer-reviewed...
Transition Therapeutics Inc - Premium Company Profile - New Research Report on Companies and Markets Company-Profile/Transition-T ..Introduction Transition Therapeutics is a biopharmaceutical company, developing novel therapeutics for disease indications with large markets.
The company's patented drug discovery technologies have helped...
Cubist Pharmaceuticals to Promote in the U.S. AstraZeneca's Broad Spectrum Antibiotic, MERREM I.V Cubist Pharmaceuticals, Inc.(CBST) today announced that it has signed an exclusive agreement with AstraZeneca (AZN) to promote and provide other support in the United States for MERREM I.V.
(meropenem for injection), an established...
Cubist Pharmaceuticals to Promote in the U.S. AstraZeneca's Broad Spectrum Antibiotic, MERREM I.V Leverages Proven U.S.Acute Care Sales Organization Complements Cubists Gram-Positive CUBICIN Company Website: http://www.cubist.com LEXINGTON, Mass.
-- (Business Wire) Cubist Pharmaceuticals, Inc.
(NASDAQ: CBST) today announced that...
Pediatric Chest Pain: Keys to the Diagnosis Children's Hospital of Michigan, Texas Children's Hospital, Children's Hospital of Michigan, and Wayne State University Dr Kundra is a fellow in the department of pediatrics and emergency medicine at Children's Hospital of Michigan in...
Use of Enhanced Surveillance for Hepatitis C Virus Infection to Detect a Cluster Among Young Injection-Drug Us _ Use of Enhanced Surveillance for Hepatitis C Virus Infection to Detect a Cluster Among Young Injection-Drug Us.
Early Results from Ongoing Clinical Study of Hepatitis C Vaccine Delivered by Inovio Biomedical's Electroporat - Inovio Biomedical Corporation (AMEX:INO), a leader in enabling the development of DNA vaccines using electroporation-based DNA delivery, announced today that its partner, Tripep AB, reported additional interim results from its ongoing...
Entecavir Boosts Hepatitis B Response After Lamivudine Failure TORONTO, July 1 -- Patients who were lamivudine (Epivir) refractory saw improved hepatitis B suppression that lasted through almost two years of treatment with entecavir (Baraclude).The percentage of patients with fewer than 300 HBV DNA...
Aethlon Medical Announces Second HIV/AIDS Treatment Site - Aethlon Medical, Inc.(OTCBB:AEMD) announced today that it has added a second HIV/AIDS clinical study location at the Bhvani Hospital in Bihar, India.
Aethlon previously disclosed plans to initiate the 'first-in-man' clinical study of...
Aethlon Medical Announces Second HIV/AIDS Treatment Site Aethlon Medical Inc (AEMD) Stock Quote, Chart, News, Add to Watchlist Aethlon Medical, Inc.AEMD announced today that it has added a second HIV/AIDS clinical study location at the Bhvani Hospital in Bihar, India.
Aethlon previously...
Aethlon Medical Announces Second HIV/AIDS Treatment Site Company Website: http://www.aethlonmedical.com SAN DIEGO -- (Business Wire) Aethlon Medical, Inc.(OTCBB:AEMD) announced today that it has added a second HIV/AIDS clinical study location at the Bhvani Hospital in Bihar, India.
Aethlon...
Entecavir May Be Effective for Hepatitis B Refractory to Lamivudine _ Entecavir May Be Effective for Hepatitis B Refractory to Lamivudine.
Alberta Vaccine Program Protect Girls From Cancer The Alberta government will be taking action to prevent the majority of cervical cancers.All girls entering grade 5 in September 2008 will be eligible to receive a vaccine that will prevent 70 per cent of cervical cancers.
Grade 9 girls...
Early Results from Ongoing Clinical Study of Hepatitis C Vaccine Delivered by Inovio Biomedical's Electroporat SAN DIEGO-- (BUSINESS WIRE) -- Inovio Biomedical Corporation (AMEX:INO), a leader in enabling the development of DNA vaccines using electroporation-based DNA delivery, announced today that its partner, Tripep AB, reported additional interim...
Entecavir May Be Effective for Hepatitis B Refractory to Lamivudine _ Entecavir May Be Effective for Hepatitis B Refractory to Lamivudine.
Ongoing Challenges in the Management of Chronic Hepatitis C _ Ongoing Challenges in the Management of Chronic Hepatitis C.
Early Results from Ongoing Clinical Study of Hepatitis C Vaccine Delivered by Inovio Biomedical's Electroporat Inovio Biomedical Corporation (AMEX:INO), a leader in enabling the development of DNA vaccines using electroporation-based DNA delivery, announced today that its partner, Tripep AB, reported additional interim results from its ongoing phase...
Hepatitis B Virus/Hepatitis C Virus Coinfection: Epidemiology, Clinical Features, Viral Interactions and Treat _ Hepatitis B Virus/Hepatitis C Virus Coinfection: Epidemiology, Clinical Features, Viral Interactions and Treat.
Early Results from Ongoing Clinical Study of Hepatitis C Vaccine Delivered by Inovio Biomedical's Electroporat - Inovio Biomedical Corporation (AMEX:INO), a leader in enabling the development of DNA vaccines using electroporation-based DNA delivery, announced today that its partner, Tripep AB, reported additional interim results from its ongoing...
